“COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS”. Frontier in Medical and Health Research, vol. 3, no. 4, June 2025, pp. 843-5, https://fmhr.net/index.php/fmhr/article/view/478.